Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Balaji Maddiboyina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Freyr Solutions, Phoenix SEZ, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Nanoparticles, Nanostructures. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
Numerous nanotech arenas in therapeutic biology have recently provided a scientific platform to manufacture a considerable swath of unique chemical entities focusing on drugs. Recently, nanoparticulate drug delivery systems have emerged to deliver a specific drug to a specified site. Among all other carriers, lipids possess features exclusive to nanostructured dosage forms. The bioavailability of orally administered drugs is typically negatively affected by their poor water solubility, resulting from the unique chemical moieties introduced. Because of their unique advantages, lipid nanoparticles must become increasingly predictable as a robust delivery mechanism. The enhanced biopharmaceutical properties and significance of lipid‐based targeting technologies such as liposomes, niosomes, solid lipid nanoparticles and micelles are highlighted in this review. Pharmaceutical implications of lipid nanocarriers for the transport and distribution of various therapeutic agents, such as biotechnological products and small pharmaceutical molecules, is a booming topic. Lipid nanoparticles as drug delivery systems have many appealing properties, including high biocompatibility, ease of preparation, tissue specificity, avoidance of reticuloendothelial systems, delayed drug release, scale‐up feasibility, nontoxicity and targeted delivery. The use of lipid nanoparticles to enhance the transport of biopharmaceuticals is currently considered state‐of‐the‐art. Similarly, we critically examine the upcoming guidelines that therapeutic scientists should handle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Freyr Solutions, Phoenix SEZ, Hyderabad, Telangana, India.
- Vishwa Bharathi College of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India.
- Nirmala College of Pharmacy, Guntur, Andhra Pradesh, India.
Zitieren
APA
Maddiboyina, B., Ramaiah, Nakkala, R. K., & Roy, H. (2023). Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14230
Vancouver
Maddiboyina B, Ramaiah, Nakkala RK, Roy H. Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14230
BibTeX
@article{Maddiboyina2023,
author = {Maddiboyina, Balaji and Ramaiah and Nakkala, Ramya Krishna and Roy, Harekrishna},
title = {Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14230}
}
EUVIMED